TY  - ADVS
AU  - Alitalo,Kari
AU  - Pytowski,Bronislawi
TI  - VEGF inhibitors for anti-angiogenic therapy
T2  - Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances,
PY  - 2007///
CY  - London
PB  - Henry Stewart Talks
KW  - Monoclonal antibodies
KW  - Neovascularization inhibitors.
KW  - Vascular endothelial growth factors
KW  - Antagonists
KW  - Angiogenesis Inducing Agents
KW  - Angiogenesis Inhibitors
KW  - pharmacology
KW  - Antibodies, Monoclonal
KW  - Neovascularization, Physiologic
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - Signal Transduction
KW  - Vascular Endothelial Growth Factor Receptor-3
KW  - antagonists & inhibitors
KW  - metabolism
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Antagonist monoclonal antibodies to VEGFR-3 -- Mode of action of antagonist monoclonal antibodies -- Functional properties of antagonist antibodies to VEGFR-3 -- In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis -- Inhibition of pathological vessel growth in the cornea -- Anti-angiogenic effect of antibodies to VEGFR-3 in tumors -- Inhibition of lymphatic metastasis with antagonist antibodies to VEGFR-3 -- Role of VEGFR-3 in normal and pathological immune response; Access restricted to subscribers
UR  - https://hstalks.com/bs/465/
UR  - https://hstalks.com/bs/p/30/
ER  -